Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models00:57

Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models

197
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
197
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

10.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
10.6K
Coagulation01:09

Coagulation

8.7K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
8.7K
Coagulation01:06

Coagulation

592
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
592

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Involvement of mitochondrial and death receptor pathways in tributyltin-induced apoptosis in rat hepatocytes" [Biochim. Biophys. Acta 1693 (2004) 15-27 (15276321)].

Biochimica et biophysica acta. Molecular cell research·2026
Same author

Macrophage Polarization Determines Inflammation Amplification and Resolution.

Bulletin of mathematical biology·2026
Same author

Local and systemic factors in the resolution of inflammation.

Journal of theoretical biology·2025
Same author

Infection propagation in a tissue with resident macrophages.

Mathematical biosciences·2025
Same author

From SIR to delay models in epidemiology: Comment on "Data-driven mathematical modeling approaches for COVID-19: A survey" by Jacques Demongeot and Pierre Magal.

Physics of life reviews·2024
Same author

Reaction-diffusion waves in biology: new trends, recent developments.

Physics of life reviews·2024
Same journal

Effects of Seasonal Births and Predation on Disease Spread.

Bulletin of mathematical biology·2026
Same journal

Identifiability, Sensitivity, and Genetic Algorithms in Bacterial Biofilm Selection Models.

Bulletin of mathematical biology·2026
Same journal

Slow Evolution Towards Generalism in a Model of Variable Dietary Range.

Bulletin of mathematical biology·2026
Same journal

CBINN: Cancer Biology-Informed Neural Network for Unknown Parameter Estimation and Missing Physics Identification.

Bulletin of mathematical biology·2026
Same journal

A Cost-Sensitive Behavioral Modeling Analysis of the Early Identification and Control of Infectious Diseases.

Bulletin of mathematical biology·2026
Same journal

Tracking Dynamics of Superspreading Through Contacts, Exposures, and Transmissions in Edge-Based Network Epidemics.

Bulletin of mathematical biology·2026
See all related articles

Related Experiment Video

Updated: Nov 11, 2025

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

9.3K

Patient-Specific Modelling of Blood Coagulation.

N Ratto1, A Bouchnita2, P Chelle3,4

  • 1UMR 5208 CNRS, Institute Camille Jordan, Ecole Centrale de Lyon, Ecully, France.

Bulletin of Mathematical Biology
|March 27, 2021
PubMed
Summary
This summary is machine-generated.

This study presents a new method for patient-specific blood coagulation modeling. It enables personalized treatment strategies for coagulation disorders by analyzing individual patient parameters.

Keywords:
Blood coagulationBlood flowReaction–diffusion wavesThrombin generation curvesTreatment

More Related Videos

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

14.1K
Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
10:25

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Published on: March 19, 2016

9.7K

Related Experiment Videos

Last Updated: Nov 11, 2025

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

9.3K
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

14.1K
Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
10:25

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Published on: March 19, 2016

9.7K

Area of Science:

  • Biomedical modeling
  • Hematology
  • Computational biology

Background:

  • Blood coagulation is extensively studied but clinical applications of its models are limited.
  • Complexity and inter-patient variability in coagulation factors hinder personalized medicine.
  • Current methods for determining patient-specific parameters are time-consuming and costly.

Purpose of the Study:

  • To develop a methodological approach for patient-specific blood coagulation modeling.
  • To enable accurate prediction of coagulation dynamics in individual patients.
  • To facilitate personalized treatment strategies for blood coagulation disorders.

Main Methods:

  • Utilized conventional thrombin generation tests.
  • Determined patient-specific parameters for a reduced kinetic model.
  • Employed computational modeling to study spatial distributions and flow dynamics.

Main Results:

  • Successfully established a method for patient-specific parameter determination.
  • Demonstrated the model's capability to analyze spatial factor distribution and coagulation in flow.
  • Provided a framework for evaluating medical treatments for coagulation disorders.

Conclusions:

  • The proposed approach overcomes limitations of current patient-specific modeling methods.
  • This methodology supports personalized medicine in managing blood coagulation disorders.
  • Enables more effective and tailored therapeutic interventions.